Market Overview

Alexza Pharmaceuticals (ALXA) Gains After Results


Alexza Pharmaceuticals, Inc. (NASDAQ: ALXA) shares climbed 4.5% to 91.74 cents after the company reported interim results from Phase 2a study of AZ-002 in epilepsy patients. Share volume totaled 1.8 million, dwarfing an all-day average of 7,900


Lightning Fast
Market News Service
$199 Free 14 Day Trial
Book A Demo
Learn How You Can Succeed In The Market With Benzinga Pro

Fastest Market News

Real-Time News Alerts

Customizable News Filters

Book A Demo